A deal that never closes and never gets killed is not a pipeline problem. It is a management problem. Zombie Pipeline is what accumulates when the professional cost of archiving a dead deal is higher than the professional cost of leaving it alive.

Zombie Pipeline looks like opportunity. In aggregate it makes coverage ratios appear comfortable, win rates appear consistent, and sales cycles appear normal. Individually, each zombie deal carries a plausible explanation: the champion went quiet, procurement is reviewing, the budget decision was pushed to next quarter. None of these explanations are obviously false. That is exactly what makes them dangerous.

The signature is not any single deal. It is the distribution. In a healthy pipeline, opportunity volume declines as deals age past the average sales cycle. In a zombie-infected pipeline, aged deals accumulate: a long tail of opportunities in the same stage for two, three, sometimes six times the median sales cycle, with activity logged periodically, close dates revised quarterly, and not a single customer-initiated contact in ninety days.

"
The deals did not disappear. They were never real. They were just more professionally convenient to leave in the system than to take out.

Pull the full opportunity list and filter for two criteria simultaneously: days in current stage greater than 1.5 times the median sales cycle for that stage, and last customer-initiated activity more than sixty days ago. Count them. Calculate their combined value as a percentage of total reported pipeline.

In the assets SLAM has assessed, this figure is rarely below 25%. It is frequently above 40%. Every percentage point represents coverage the forward model is relying on that will not convert.

The second test: ask three reps to describe, without opening the CRM, the last conversation they had with the economic buyer on their oldest active deal. If the answer involves anything other than a direct exchange with a budget holder, the deal is a zombie regardless of what stage it is in.

Reps keep dead deals alive because the CRM is a managerial audience, not an operational tool. A pipeline with twenty-two deals looks more professional than one with fourteen. Archiving a deal produces an immediate, visible loss with no corresponding gain. The rep who kills a dead deal quickly is, in most organisations, not celebrated. They are questioned.

This is a management architecture failure, not a rep behaviour failure. Organisations that celebrate fast qualification equally with fast closing produce clean pipelines. Organisations that treat pipeline volume as a proxy for effort produce zombies.

Zombie Pipeline creates two distinct valuation risks. The first is direct: the headline coverage figure is inflated and the forward revenue model the acquisition thesis depends on is overstated. A reported 3.2x pipeline coverage that reduces to 1.8x after zombie removal is not a detail. It is the thesis.

The second is structural. A salesforce rewarded for pipeline inflation has been simultaneously punished for pipeline honesty. Reversing that incentive signal after acquisition takes longer than a quarterly comp plan revision. The ghost deals disappear faster than the behaviour that produced them.

Risk Classification: Behavioural Risk (primary) / Execution Risk (secondary)
Behaviour Observed
Aged, non-progressing deals are maintained in the pipeline to avoid the professional cost of archiving, inflating coverage and distorting the forward revenue picture.
Why This Happens
Archiving a deal is immediately visible and feels like a loss. Leaving it in the pipeline is invisible and costs nothing in the short term. Reps optimise for the short term.
Investment Risk
Headline pipeline coverage is not a reliable input to the forward model without zombie removal. In SLAM assessments, the zombie-adjusted coverage figure is typically 30-50% below the reported one.
Implication for the Investment Committee
Do not accept pipeline coverage ratios without a zombie-adjusted recalculation. Request raw opportunity data with timestamps. The recalculated figure is the only one that belongs in the model.
Valuation Risk HIGH
Forecast Risk HIGH
Execution Risk MEDIUM